In utero to exposure to female hormones and germ cell tumors in children

Cancer

Volumn 106, Issue 5, 2006, Pages 1169-1177

  Shankar, Sadhna ^a   Davies, Stella ^b   Giller, Roger ^c   Krailo, Mark ^d   Davis, Mary ^e   Gardner, Kathleen ^a   Cai, Hui ^a   Robison, Leslie ^f   Shu, Xiao Ou ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e RILEY HOSPITAL FOR CHILDREN   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Exogenous female hormones; Germ cell tumor

Indexed keywords

CORTICOSTEROID; ESTROGEN; HORMONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ADOLESCENT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ESTROGENS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; ODDS RATIO; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROGESTINS; RISK FACTORS;

EID: 33644512410     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21670     Document Type: Article

References (52)

1. Young JL Jr., Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986;58:598-602.
2. Muir KR, Parkes SE, Lawson S, Thomas AK, Cameron AH, Mann JR. Changing incidence and geographical distribution of malignant paediatric germ cell tumors in the West Midlands Health Authority region, 1957-92. Br J Cancer. 1995;72:219-223.
3. Pinkerton CR. Malignant germ cell tumors in childhood. Eur J Cancer. 1997;33:895-902.
4. dos Santos Silva I, Swerdlow AJ, Stiller C, Reid A. Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. Int J Cancer. 1999;83:630-634.
5. Glazer ER, Perkins CI, Young JL Jr., Schlag RD, Campleman SL, Wright WE. Cancer among Hispanic children in California, 1988-1994: comparison with non-Hispanic white children. Cancer. 1999;86:1070-1079.
6. Birch JM, Marsden HB, Swindell R. Incidence of malignant disease in childhood: a 24-year review of the Manchester Children's Tumor Registry data. Br J Cancer. 1980;42:215-223.
7. Birch JM, Marsden HB, Swindell R. Pre-natal factors in the origin of germ cell tumors of childhood. Carcinogenesis. 1982;3:75-80.
8. Brown LM, Pottern LM, Hoover RN, Devesa SS, Aselton R, Flannery JT. Testicular cancer in United States: trends in incidence and mortality. Int J Epidemiol. 1986;15:164-170.
9. Spitz MR, Sider JG, Pollack ES, Lynch HK, Newell GR. Incidence and descriptive features of testicular cancer among United States whites, blacks, and Hispanics, 1973-1982. Cancer. 1986;58:1785-1790.
10. McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003;97:3-70.
11. Walker AH, Ross RK, Pike MC, Henderson BE. A possible rising incidence of malignant germ cell tumors in young women. Br J Cancer. 1984;49:669-672.
12. dos Santos Silva I, Swerdlow AJ. Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer. Br J Cancer. 1991;63:814-818.
13. Moller H, Evans H. Epidemiology of gonadal germ cell cancer in males and females. APMIS. 2003;11:3-46.
14. Schnider DT, Calaminus G, Koch S, et al. Epidemilogical analysis of 1,442 children and adolescents registered in German germ cell tumor protocols. Pediatr Blood Cancer. 2004;42:169-175.
15. Schnider DT, Shuster AE, Fritsch MK, et al. Multipoint imprinting analysis indicates a common precursor cell for gonadal and non-gonadal pediatric germ cell tumors. Cancer Res. 2001;61:7268-7276.
16. Bussey KJ, Lawce HJ, Himoe E, et al. SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development. Genes Chromosomes Cancer. 2001;32:342-352.
17. van Gurp RJ, Oosterhuis JW, Kalcheuer V, et al. Biallelic expression of the H19 and the insulin-like growth factor-2 in pediatric germ cell tumors. J Natl Cancer Inst. 1994;86:1070-1075.
18. Ross JA, Schmidt PT, Parentesis JP, et al. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors. Cancer. 1999;85:1389-1394.
19. Andervont HB, Shimkin MB, Canter HY. The growth of estrogen-induced interstitial-cell testicular tumors in BALB/c mice. J Natl Cancer Inst. 1960;24:1219-1237.
20. Nomura T, Kanzaki T. Induction of urogenital anomalies and some tumors in the progeny of mice receiving diethylstilbestrol during pregnancy. Cancer Res. 1977;37:1099-1104.
21. McLachlan JA, Newbold RR, Bullock B. Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol. Science. 1975;190:991-992.
22. Coscrove MD, Benton B, Henderson BE. Male genitourinary abnormalities and maternal diethylstilbestrol. J Urol. 1977;117:220-222.
23. Chilvers C, Pike MC. Epidemiology of undescended testis. In: Oliver RTD, editor. Urological and genital cancer. Oxford: Blackwell, 1989:306-321.
24. Rothman KJ, Louik C. Oral contraceptives and birth defects. N Engl J Med. 1978;299:522-524.
25. Torfs CP, Milkovich L, van den Berg BJ. The relationship between hormonal pregnancy tests and congenital anomalies: a prospective study. Am J Epidemiol. 1981;113:563-574.
26. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst. 1983;71:1151-1155.
27. Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer. 1979;23:598-602.
28. Schottenfeld D, Warshauer ME, Sherlock S, Zauber AG, Leder M, Payne R. The epidemiology of testicular cancer in young adults. Am J Epidemiol. 1980;112:232-246.
29. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer. 2000;87:438-443.
30. Walker AH, Ross RK, Haile RW, Henderson BE. Hormonal factors and risk of ovarian germ cell cancer in young women. Br J Cancer. 1988;57:418-422.
31. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol. 1984;120:825-833.
32. Breslow NE, Day NE. Statistical methods in cancer research. I. The analysis of case-control studies. IARC Sci Publ. 1980;32:5-338.
33. Moss AR, Osmond D, Bacchetti P, Torti FM, Gurgin V. Hormonal risk factors in testicular cancer: a case-control study. Am J Epidemiol. 1986;124:39-52.
34. Brown LM, Pottern LM, Hoover RN. Prenatal and perinatal risk factors for testicular cancer. Cancer Res. 1986;46:4812-4816.
35. Strohsnitter WC, Noller KL, Hoover RN, et al. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst. 2001;93:545-551.
36. Swerdlow AJ, Stiller CA, Wilson LM. Prenatal factors in the etiology of testicular cancer: an epidemiological study of childhood testicular cancer deaths in Great Britain, 1953-73. J Epidemiol Commun Health. 1982;36:96-101.
37. Johnston HE, Mann JR, Williams J, et al. The Inter-Regional, Epidemiological Study of Childhood Cancer (IRESCC): case-control study in children with germ cell tumors. Carcinogenesis. 1986;7:717-722.
38. Shu XO, Nesbit ME, Buckley JD, Krailo MD, Robison LL. An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Children's Cancer Group (Canada, United States). Cancer Causes Control. 1995;6:187-198.
39. Zeisler H, Jirecek S, Hohlagschwandtner M, Knofler M, Tempfer C, Livingston JC. Concentrations of estrogens in patients with preeclampsia. Wien Klin Wochenschr. 2002;114:458-461.
40. Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology. 1991;10:722-732.
41. Zamudio S, Leslie KK, White M, Hagerman DD, Moore LG. Low serum estradiol and high serum progesterone concentrations characterize hypertensive pregnancies at high altitude. J Soc Gynecol Invest. 1991;1:197-205.
42. Lagiou P, Tamimi R, Mucci LA, Trichopoulos D, Adami HO, Hsieh CC. Nausea and vomiting in pregnancy in relation to prolactin, estrogens, and progesterone: A prospective study. Obstet Gynecol. 2003;101:639-644.
43. Furneaux EC, Langley-Evans AJ, Langley-Evans SC. Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstet Gynecol Suru. 2001;56:775-782.
44. Szabo I, Szilagyi A. Management of threatened abortion. Early Pregnancy. 1996;2:233-240.
45. al-Sebai MA, Kingsland CR, Diver M, Hipkin L, McFadyen IR. The role of a single progesterone measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. Br J Obstet Gynecol. 1995;102:364-369.
46. MacMahon B, Trichopoulos D, Cole P, Brown J. Cigarette smoking and urinary estrogens. N Engl J Med. 1982;207:1062-1065.
47. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol. 1990;162:502-514.
48. United Kingdom Testicular Cancer Study Group. Etiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. Br Med J. 1994;308:1393-1399.
49. Pettersson A, Kaijser M, Richiardi L, Askling J, Ekbom A, Akre O. Women smoking and testicular cancer: one epidemic causing another? Int J Cancer. 2004;109:941-944.
50. Gershman ST, Stolley PD. A case-control study of testicular cancer using Connecticut tumour registry data. Int J Epidemiol. 1998;17:738-742.
51. Rasmussen F, Gunnell D, Ekbom A, Hallqvist J, Tynelius P. Birth weight, adult height, and testicular cancer: cohort study of 337,249 Swedish young men. Cancer Causes Control. 2003;14:595-598.
52. Olson IE, Shu XO, Ross JA, Pendergrass T, Robison LL. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol. 1997;145:8-67.